References
- Pitti, R M.; Marsters, S A.; Ruppert, S.; Donahue, C J.; Moore, A.; Ashkenazi, A. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family.J. Biol. Chem. 1996, 271, 12687–12690. [PUBMED], [INFOTRIEVE], [CSA]
- Wiley, S R.; Schooley, K.; Smolak, P J.; Din, W S.; Huang, C P.; Nicholl, J K.; Sutherland, G R.; Smith, T D.; Rauch, C.; Smith, C A. Identification and characterization of a new member of the TNF family that induces apoptosis.Immunity 1995, 3, 673–682. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Pan, G.; O'Rourke, K.; Chinnaiyan, A M.; Gentz, R.; Ebner, R.; Ni, J.; Dixit, V M. The receptor for the cytotoxic ligand TRAIL.Science 1997, 276, 111–113. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Pan, G.; Ni, J.; Wei, Y F.; Yu, G.; Gentz, R.; Dixit, V M. An antagonist decoy receptor and a death domain-containing receptor for TRAIL.Science 1997, 277, 815–818. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Emery, J G.; McDonnell, P.; Burke, M B.; Deen, K C.; Lyn, S.; Silverman, C.; Dul, E.; Appelbaum, E R.; Eichman, C.; DiPrinzio, R.; Dodds, R A.; James, I E.; Rosenberg, M.; Lee, J C.; Young, P R. Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL.J. Biol. Chem. 1998, 273, 14363–14367. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Ashkenazi, A.; Pai, R C.; Fong, S.; Leung, S.; Lawrence, D A.; Marsters, S A.; Blackie, C.; Chang, L.; McMurtrey, A E.; Hebert, A.; DeForge, L.; Koumenis, I L.; Lewis, D.; Harris, L.; Bussiere, J.; Koeppen, H.; Shahrokh, Z.; Schwall, R H. Safety and antitumor activity of recombinant soluble Apo2 ligand.J. Clin. Invest. 1999, 104, 155–162. [PUBMED], [INFOTRIEVE], [CSA]
- Walczak, H.; Miller, R E.; Ariail, K.; Gliniak, B.; Griffith, T S.; Kubin, M.; Chin, W.; Jones, J.; Woodward, A.; Le, T.; Smith, C.; Smolak, P.; Goodwin, R G.; Rauch, C T.; Schuh, J C.; Lynch, D H. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.Nat. Med. 1999, 5, 157–163. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Chang, L.; Karin, M. Mammalian MAP kinase signalling cascades.Nature 2001, 410, 37–40. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Schaeffer, H J.; Weber, M J. Mitogen-activated protein kinases: specific messages from ubiquitous messengers.Mol. Cell. Biol. 1999, 19, 2435–2444. [PUBMED], [INFOTRIEVE], [CSA]
- Tsukada, Y.; Miyazawa, K.; Kitamura, N. High intensity ERK signal mediates hepatocyte growth factor-induced proliferation inhibition of the human hepatocellular carcinoma cell line HepG2.J. Biol. Chem. 2001, 276, 40968–40976. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Nagata, Y.; Todokoro, K. Requirement of activation of JNK and p38 for environmental stress-induced erythroid differentiation and apoptosis and of inhibition of ERK for apoptosis.Blood 1999, 94, 853–863. [PUBMED], [INFOTRIEVE], [CSA]
- She, Q B.; Chen, N.; Dong, Z. ERKs and p38 kinase phosphorylate p53 protein at serine 15 in response to UV radiation.J. Biol. Chem. 2000, 275, 20444–20449. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Gomez-Santos, C.; Ferrer, I.; Reiriz, J.; Vinals, F.; Barrachina, M.; Ambrosio, S. MPP+ increases alpha-synuclein expression and ERK/MAP-kinase phosphorylation in human neuroblastoma SH-SY5Y cells.Brain Res. 2002, 935, 32–39. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Xia, Z.; Dickens, M.; Raingeaud, J.; Davis, R J.; Greenberg, M E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis.Science 1995, 270, 1326–1331. [PUBMED], [INFOTRIEVE], [CSA]
- Gardner, A M.; Johnson, G L. Fibroblast growth factor-2 suppression of tumor necrosis factor alpha-mediated apoptosis requires Ras and the activation of mitogen-activated protein kinase.J. Biol. Chem. 1996, 271, 14560–14566. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Berra, E.; Diaz-Meco, M T.; Moscat, J. The activation of p38 and apoptosis by the inhibition of Erk is antagonized by the phosphoinositide 3-kinase/Akt pathway.J. Biol. Chem. 1998, 273, 10792–10797. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Merienne, K.; Jacquot, S.; Zeniou, M.; Pannetier, S.; Sassone-Corsi, P.; Hanauer, A. Activation of RSK by UV-light: phosphorylation dynamics and involvement of the MAPK pathway.Oncogene 2000, 19, 4221–4229. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Tsai, E Y.; Falvo, J V.; Tsytsykova, A V.; Barczak, A K.; Reimold, A M.; Glimcher, L H.; Fenton, M J.; Gordon, D C.; Dunn, I F.; Goldfeld, A E. A lipopolysaccharide-specific enhancer complex involving Ets, Elk-1, Sp1, and CREB binding protein and p300 is recruited to the tumor necrosis factor alpha promoter in vivo.Mol. Cell. Biol. 2000, 20, 6084–6094. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Desire, L.; Courtois, Y.; Jeanny, J C. Endogenous and exogenous fibroblast growth factor 2 support survival of chick retinal neurons by control of neuronal neuronal bcl-x(L) and bcl-2 expression through a fibroblast berowth factor receptor 1- and ERK-dependent pathway.J. Neurochem. 2000, 75, 151–163. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Boucher, M J.; Morisset, J.; Vachon, P H.; Reed, J C.; Laine, J.; Rivard, N. MEK/ERK signaling pathway regulates the expression of Bcl-2, Bcl-X(L), and Mcl-1 and promotes survival of human pancreatic cancer cells.J. Cell. Biochem. 2000, 79, 355–369. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Domen, J.; Gandy, K L.; Weissman, I L. Systemic overexpression of BCL-2 in the hematopoietic system protects transgenic mice from the consequences of lethal irradiation.Blood 1998, 91, 2272–2282. [PUBMED], [INFOTRIEVE], [CSA]
- Srivastava, R K.; Sasaki, C Y.; Hardwick, J M.; Longo, D L. Bcl-2-mediated drug resistance: inhibition of apoptosis by blocking nuclear factor of activated T lymphocytes (NFAT)-induced Fas ligand transcription.J. Exp. Med. 1999, 190, 253–265. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Garland, J M.; Halestrap, A. Energy metabolism during apoptosis. Bcl-2 promotes survival in hematopoietic cells induced to apoptose by growth factor withdrawal by stabilizing a form of metabolic arrest.J. Biol. Chem. 1997, 272, 4680–4688. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Park, S A.; Park, H J.; Lee, B I.; Ahn, Y H.; Kim, S U.; Choi, K S. Bcl-2 blocks cisplatin-induced apoptosis by suppression of ERK-mediated p53 accumulation in B104 cells.Brain Res. Mol. Brain Res. 2001, 93, 18–26. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Sun, S Y.; Yue, P.; Zhou, J Y.; Wang, Y.; Choi Kim, H R.; Lotan, R.; Wu, G S. Overexpression of BCL2 blocks TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in human lung cancer cells.Biochem. Biophys. Res. Commun. 2001, 280, 788–797. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Ashkenazi, A.; Dixit, V M. Death receptors: signaling and modulation.Science 1998, 281, 1305–1308. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Lee, Y J.; Lee, K H.; Kim, H R.; Jessup, J M.; Seol, D W.; Kim, T H.; Billiar, T R.; Song, Y K. Sodium nitroprusside enhances TRAIL-induced apoptosis via a mitochondria-dependent pathway in human colorectal carcinoma CX-1 cells.Oncogene 2001, 20, 1476–1485., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Muhlenbeck, F.; Haas, E.; Schwenzer, R.; Schubert, G.; Grell, M.; Smith, C.; Scheurich, P.; Wajant, H. TRAIL/Apo2L activates c-Jun NH2-terminal kinase (JNK) via caspase-dependent and caspase-independent pathways.J. Biol. Chem. 1998, 273, 33091–33098. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Lee, M W.; Park, S C.; Yang, Y G.; Yim, S O.; Chae, H S.; Bach, J H.; Lee, H J.; Kim, K Y.; Lee, W B.; Kim, S S. The involvement of reactive oxygen species (ROS) and p38 mitogen-activated protein (MAP) kinase in TRAIL/Apo2L-induced apoptosis.FEBS Lett. 2002, 512, 313–318. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Goillot, E.; Raingeaud, J.; Ranger, A.; Tepper, R I.; Davis, R J.; Harlow, E.; Sanchez, I. Mitogen-activated protein kinase-mediated Fas apoptotic signaling pathway.Proc. Natl. Acad. Sci. U. S. A. 1997, 94, 3302–3307. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Jimenez, L A.; Zanella, C.; Fung, H.; Janssen, Y M.; Vacek, P.; Charland, C.; Goldberg, J.; Mossman, B T. Role of extracellular signal-regulated protein kinases in apoptosis by asbestos and H2O2.Am. J. Physiol. 1997, 273 (5 Pt 1), L1029–L1035. [PUBMED], [INFOTRIEVE], [CSA]
- Kim, M S.; So, H S.; Park, J S.; Lee, K M.; Moon, B S.; Lee, H S.; Kim, T Y.; Moon, S K.; Park, R. Hwansodan protects PC12 cells against serum-deprivation-induced apoptosis via a mechanism involving Ras and mitogen-activated protein (MAP) kinase pathway.Gen. Pharmacol. 2000, 34, 227–235. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Wilson, D J.; Alessandrini, A.; Budd, R C. MEK1 activation rescues Jurkat T cells from Fas-induced apoptosis.Cell. Immunol. 1999, 194, 67–77. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Luttrell, L M.; Daaka, Y.; Lefkowitz, R J. Regulation of tyrosine kinase cascades by G-protein-coupled receptors.Curr. Opin. Cell Biol. 1999, 11, 177–183. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Zhang, C.; Qiu, H E.; Krafft, G A.; Klein, W L. Protein kinase C and F-actin are essential for stimulation of neuronal FAK tyrosine phosphorylation by G-proteins and amyloid beta protein.FEBS Lett. 1996, 386, 185–188. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Marais, R.; Light, Y.; Mason, C.; Paterson, H.; Olson, M F.; Marshall, C J. Requirement of Ras-GTP-Raf complexes for activation of Raf-1 by protein kinase C.Science 1998, 280, 109–112. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Luttrell, L M.; Daaka, Y.; Della Rocca, G J.; Lefkowitz, R J. G protein-coupled receptors mediate two functionally distinct pathways of tyrosine phosphorylation in rat 1a fibroblasts. Shc phosphorylation and receptor endocytosis correlate with activation of Erk kinases.J. Biol. Chem. 1997, 272, 31648–31656. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Hiwasa, T.; Arase, Y.; Chen, Z.; Kita, K.; Umezawa, K.; Ito, H.; Suzuki, N. Stimulation of ultraviolet-induced apoptosis of human fibroblast UVr-1 cells by tyrosine kinase inhibitors.FEBS Lett. 1999, 444, 173–176. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Papazisis, K T.; Zambouli, D.; Kimoundri, O T.; Papadakis, E S.; Vala, V.; Geromichalos, G D.; Voyatzi, S.; Markala, D.; Destouni, E.; Boutis, L.; Kortsaris, A H. Protein tyrosine kinase inhibitor, genistein, enhances apoptosis and cell cycle arrest in K562 cells treated with gamma-irradiation.Cancer Lett. 2000, 160, 107–113. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kasof, G M.; Lu, J J.; Liu, D.; Speer, B.; Mongan, K N.; Gomes, B C.; Lorenzi, M V. Tumor necrosis factor-alpha induces the expression of DR6, a member of the TNF receptor family, through activation of NF-kappaB.Oncogene 2001, 55, 7965–7975. [CSA], [CROSSREF]
- Srivastava, R K. TRAIL/Apo-2L: mechanisms and clinical applications in cancer.Neoplasia 2001, 6, 535–546. [CSA], [CROSSREF]
- Fulda, S.; Meyer, E.; Debatin, K M. Inhibition of TRAIL-induced apoptosis by Bcl-2 overexpression.Oncogene 2002, 21, 2283–2294. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]